BlackRock Advisors’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $265K | Sell |
12,955
-315
| -2% | -$6.44K | ﹤0.01% | 2503 |
|
|
2016
Q3 | $199K | Buy |
13,270
+4,471
| +51% | +$67K | ﹤0.01% | 2636 |
|
|
2016
Q2 | $95K | Buy |
8,799
+4,722
| +116% | +$51K | ﹤0.01% | 2940 |
|
|
2016
Q1 | $55K | Buy |
4,077
+393
| +11% | +$5.3K | ﹤0.01% | 3081 |
|
|
2015
Q4 | $68K | Sell |
3,684
-1,608
| -30% | -$29.7K | ﹤0.01% | 3043 |
|
|
2015
Q3 | $134K | Buy |
+5,292
| New | +$134K | ﹤0.01% | 2915 |
|